Telmisartan versus Enalapril in heart failure with reduced ejection fraction patients with moderately impaired kidney functions; randomized controlled trial. (TRIUMF trial)
20 May 2023 (08:00 - 20:00)
Organised by: 
About the speaker
Kasr Al Ainy School of Medicine, Cairo (Egypt)
7 More presentations in this session
Doctor R. Bin Raja Shariff (Selangor, MY)
Doctor Y. Nishihata (Tokyo, JP)
Doctor A. Garcia (Lisbon, PT)
Access the full session
The Event
Heart Failure 2023
20 May - 23 May 2023
You may be interested in
Congress Presentation
Congress Presentation
